• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    AstraZeneca Pharma India Ltd.
    18 Jul 2025
    8811.50
    -2.39%
    Here's why AstraZeneca Pharma share price is down over 2% today
    Business Standard
    The decline in the company's share price came as its shares traded ex-date following the announcement of a 32 per share dividend
    Copy LinkShare onShare on Share on Share on
    AstraZeneca Pharma India Ltd. is trading above its 200 day SMA of 8188.7
    logo
    Torrent Pharmaceuticals Ltd.
    18 Jul 2025
    3561.00
    0.83%
    Torrent Pharma seeks CCI nod for 19,500 cr majority stake in JB Chemicals
    Business Standard
    Ahmedabad-based Torrent Pharmaceuticals has sought fair trade regulator CCI's clearance to acquire a majority stake in in J B Chemicals and Pharmaceuticals in a Rs 19,500-crore deal. After the completion of the deal, Torrent Pharmaceuticals will become India's second most valued pharma company. The development came after Torrent Pharmaceuticals in June this year announced the acquisition of a majority stake in J B Chemicals and Pharmaceuticals in a Rs 19,500-crore deal. "The proposed combination relates to acquisition of shareholding by the acquirer (Torrent Pharmaceuticals Ltd) in the target (J B Chemicals & Pharmaceuticals Ltd) and the subsequent amalgamation of the target with the acquirer," according to a notice filed with the Competition Commission of India (CCI). Torrent Pharmaceuticals is the flagship company of the Torrent group and is engaged in the business of manufacturing and sale of pharmaceutical formulations (FDFs) across therapeutic segments. J B Chemicals &...
    Copy LinkShare onShare on Share on Share on
    Torrent Pharmaceutic.. has an average target of 3746.00 from 5 brokers.
    Torrent Pharma seeks CCI nod to acquire majority stake in JB Chemicals for 19,500 cr
    Business Line | 18 Jul 2025
    logo
    Laurus Labs Ltd.
    17 Jul 2025
    High Loss High Volume
    832.30
    -7.15%
    Andhra okays 39,473 cr investment across 22 projects, 30k+ jobs ahead
    Business Standard
    The eighth State Investment Promotion Board of Andhra Pradesh headed by Chief Minister N Chandrababu Naidu on Thursday approved 22 projects worth Rs 39,473 crore with the scope to generate 30,899 jobs, the government said. The CM directed ministers and officials to create the relevant ecosystem around the industrial projects coming up in the state. "The eighth SIPB headed by CM Chandrababu approved investments worth Rs 39,473 crore. The 22 projects approved today will provide jobs to 30,899 people," an official release said. The approved projects included an investment of Rs 1,800 crore from Renew Vyoman Power Pvt Ltd in Kurnool and Nandyal districts, JSW Neo Energy (Rs 2,000 crore; Kadapa), JSW AP Steel Plant (Rs 4,500 crore; Kadapa) and Laurus Labs (Rs 5,630 crore; Anakapalli). Other projects included Lulu Shopping Malls International Ltd (Rs 1,222 crore; Vizag & Vijayawada), Renew Photovoltaic (Rs 3,700 crore; Anakapalli) and AS International (Rs 1,000 crore; Chittoor), among ..
    Copy LinkShare onShare on Share on Share on
    Laurus Labs Ltd.'s price crossed below 50Day SMA today
    logo
    Glenmark Pharmaceuticals Ltd.
    17 Jul 2025
    Dividend
    1971.70
    -2.91%
    Glenmark Pharma Will Turn Cash Positive With AbbVie's Licensing Deal: SP
    Glenmark Pharma Will Turn Cash Positive With AbbVie's Licensing Deal: SP
    NDTV Profit
    Glenmark, through wholly-owned subsidiary IGI Therapeutics SA, announced an exclusive licensing agreement with AbbVie for ISB 2001.
    Copy LinkShare onShare on Share on Share on
    Glenmark Pharmaceuticals Ltd. is trading above its 200 day SMA of 1653.1
    logo
    Lupin Ltd.
    17 Jul 2025
    1919.80
    -2.23%
    Lupin share price increases on rolling out eye medication; details here
    Business Standard
    Lupin's share price rose today after the company announced the launch of Loteprednol Etabonate Ophthalmic Suspension, 0.5 per cent, in the US market.
    Copy LinkShare onShare on Share on Share on
    Lupin Ltd.'s price crossed below 50Day SMA today
    logo
    Novartis India Ltd.
    17 Jul 2025
    875.70
    -1.35%
    Novartis cannot block generic version of Entresto, judge rules
    Business Line
    The judge also reversed her prior ruling that Novartis would likely prove that MSN's tablets looked too similar to Entresto and would confuse consumers
    Copy LinkShare onShare on Share on Share on
    Novartis India Ltd. is trading below all available SMAs
    logo
    Emcure Pharmaceuticals Ltd.
    17 Jul 2025
    1284.20
    -3.14%
    Emcure Pharma, Sanofi India shares edge higher; what's behind the move?
    Business Standard
    Emcure Pharma stock was quoting at 1,382.5, up 1.5 per cent from the previous day's close of 1,362.5 as the company announced a distribution and promotion partnership with Sanofi India
    Copy LinkShare onShare on Share on Share on
    Emcure Pharmaceuticals Ltd. is trading above its 200 day SMA of 1244.3
    Emcure Pharmaceuticals to distribute Sanofi's oral anti-diabetic drugs
    Business Line | 16 Jul 2025
    logo
    Cipla Ltd.
    16 Jul 2025
    1499.40
    -0.68%
    Cipla at 90, to provide quality, affordable products, says YK Hamied
    Business Line
    Respiratory and Obesity products, among focus areas reiterated by top management
    Copy LinkShare onShare on Share on Share on
    Cipla Ltd. has an average target of 1702.60 from 10 brokers.
    logo
    Sanofi Consumer Healthcare India Ltd.
    16 Jul 2025
    4940.50
    0.79%
    Emcure enters distribution agreement with Sanofi for diabetes drugs
    Business Standard
    Emcure to distribute and promote Sanofi's oral anti-diabetic brands Amaryl and Cetapin in India, expanding access amid rising prevalence of uncontrolled diabetes
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors decreased from 136 to 114 in Jun 2025 qtr
    logo
    Shilpa Medicare Ltd.
    16 Jul 2025
    Bonus
    771.85
    -2.63%
    Why did Shilpa Medicare share jump 5% in trade today? top details here
    Business Standard
    Shilpa Medicare share price gained in trade after the company announced a positive regulatory update from the US health regulator, United States Food and Drug Administration (USFDA).
    Copy LinkShare onShare on Share on Share on
    Shilpa Medicare Ltd. is trading below all available SMAs
    more
    loading
    Trendlyne Logo Trendlyne
    Stay ahead of the market
    Markets Today
    • Nifty 50 today
    • Sensex today
    • Latest Quarterly results
    • FII & DII data today
    Dashboard
    • Industry & Sector analysis
    • ETFs
    • Mutual Funds
    • Bullish & Bearish spread
    • Global Indices
    Tools
    • Compare stocks
    • Widgets
    • Data Downloader
    • Excel Connect
    IPOs
    • Dashboard (Mainboard & SME)
    • Upcoming IPOs
    • Recently Listed IPOs
    • Most Successful IPOs
    Upcoming IPOs
    • Jinkushal Industries
    • Chatterbox Technologies
    • Rukmani Devi Garg Agro Impex
    Quick Links
    • Contact us
    • Blogs
    • FAQs
    Company
    • Privacy
    • Terms of Use
    • Disclaimer
    Trendlyne Products
    • Starfolio
    • SmartOptions
    • Trendlyne US Global
    Get Mobile App
    • Android
    • iOS

    Copyright © 2025 Giskard Datatech Pvt Ltd (RA SEBI Reg No: INH000022507)